MedPath

ViiV Healthcare UK Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.viivhealthcare.com

Clinical Trials

8

Active:8
Completed:0

Trial Phases

1 Phases

Phase 1:4

Drug Approvals

20

EMC:20

Drug Approvals

Retrovir 250mg Capsules

Approval Date
Jul 7, 2025
EMC

Juluca 50 mg/25 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Vocabria 30 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Tivicay 10 mg Film-Coated Tablets

Approval Date
Jul 7, 2025
EMC

Epivir 10 mg/ml Oral Solution

Approval Date
Jul 7, 2025
EMC

Ziagen 300 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Kivexa 600 mg/300 mg film-coated tablets

Approval Date
Jul 7, 2025
EMC

Celsentri 20 mg/ml oral solution

Approval Date
Jul 7, 2025
EMC
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.